Lecture Details - Table of Contents

Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies

Release Date: May 11, 2009| Apr 24-25, 2009, Asheville, NC

Table of Contents

Multiple Myeloma Case-Based Discussion
Heather Brumbaugh

Multiple Myeloma Case-Based Discussion
Angela Johns

Multiple Myeloma Case-Based Discussion
Martha Lassiter

Rasburicase for Tumor Lysis System Prevention and Treatment
Ashley Morris Engemann

CMS Reimbursement Changes Pertaining to Erythroid-Stimulating Agents and the Impact of Those Changes on Clinical Practice
Sally Y. Barbour

Symptom Management
Krista Rowe

Marginal Zone Lymphomas: Not One but Three Diseases
Patrick Buckley

Cytogenetic Abnormalities in MALT Lymphomas and Comparative Genomic Hybridization Testing
Barbara Goodman

When a Clonal B or T Cell Is NOT a Lymphoma: Lessons Learned From MALT Lymphoma
Michael B. Datto

Debate: Best Consolidation Therapy for Adult Acute Lymphoblastic Leukemia—Transplantation for All?
Jon Gockerman

Case-Based Discussion: Standard 7 + 3 Induction Therapy in the Elderly Patient With Acute Myeloid Leukemia
Joseph Moore

Novel Therapies for the Treatment of Acute Myeloid Leukemia in the Elderly
Judith Karp

Chronic Myeloid Leukemia Case-Based Discussion: What Do I Do? When Do I Do It? Why Do I Do It?
Ronan Swords

Erythropoietin Use Guidelines
Gary H. Lyman

Indications for Thrombopoietin Receptor Agonists
Thomas L. Ortel

Case-Based Minisymposium on Venous Thromboembolism: Risk Factors, Prevention, and Treatment Strategies
Alok Khorana
Gary H. Lyman
Thomas L. Ortel

Instructions for Participation

To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>

To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>

Read all of the conditions in the Activity Terms box below. You must accept the Activity Terms in order to continue:

Disclaimer
Physicians’ Education Resource presents this resource for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. Please consult full prescribing information for any drugs or procedures discussed within.

The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this publication to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.

Disclosure of Unlabeled Uses
This reference may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physician’s Desk Reference.

All rights reserved; for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.

Software Requirements
The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.

If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.

PC Users
If you need to upgrade your Web browser, follow one of the links listed below:

Macintosh Users
Compatible Web browsers include

Educational Grants

An educational grant for this activity was provided by:


  1. Cephalon Oncology
  2. Genentech BioOncology/
    Biogen Idec
  4. Celgene Corporation
  5. Eisai, Inc.
  6. Millennium Pharmaceuticals
  7. Otsuka America Pharmaceutical, Inc.
  9. Amgen
  10. Biogen Idec
  11. Florida Hospital Cancer Institute
  12. Genzyme Oncology, a business unit of Genzyme Corporation
  13. sanofi-aventis U.S.